Abacus Wealth Partners »

Regeneron Pharmaceuticals shares owned by Abacus Wealth Partners

Quarter-by-quarter ownership of Regeneron Pharmaceuticals (REGN) shares owned by Abacus Wealth Partners from 13F filings

Historical chart of Abacus Wealth Partners investment in Regeneron Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Regeneron Pharmaceuticals held by Abacus Wealth Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Regeneron Pharmaceuticals by Abacus Wealth Partners

Quarter filed Position value Share count Share price at filing
2025-12-31 $880k 1.1k 771.87

More positions owned by Abacus Wealth Partners

Vert Global Sustainable Real Estate ETF Etf (VGSR)
DFA Dimensional Glbl Sustainability Fx Inc ETF Etf (DFSB)
Dimensional U S Targeted Value ETF Etf (DFAT)
Nuveen ESG Small-Cap ETF Etf (NUSC)
Adasina Social Justice All Cap Global ETF Etf (JSTC)
Dimensional US Sustainability Core 1 ETF Etf (DFSU)
Nuveen ESG Mid-Cap Value ETF Etf (NUMV)
Dimensional Intl Sustainability Core 1 ETF Etf (DFSI)
Nuveen ESG Emerging Markets Equity ETF Etf (NUEM)
Nvidia Corp Common Stock (NVDA)
Apple Common Stock (AAPL)
Dimensional Emg Mkts Sustainability Core 1 ETF Etf (DFSE)
Microsoft Corp Common Stock (MSFT)
Dimensional Intern Small Cap VL ETF Etf (DISV)
Taiwan Semiconductor M F Common Stock (TSM)

View all positions for Abacus Wealth Partners

Top funds holding Regeneron Pharmaceuticals

Vanguard Group
BlackRock
State Street Corporation
Dodge & Cox
Jpmorgan Chase & Co
Franklin Resources
Geode Capital Management
Nuveen
FMR
Loomis, Sayles and
Invesco
Capital World Investors
Susquehanna International
Goldman Sachs Group
Norges Bank Investment Management

View all funds holding Regeneron Pharmaceuticals